Actavalon Announces Appointment of Dr. John Hood to Its Board of Directors
SAN DIEGO, August 14, 2018 (PR NEWSWIRE) –Actavalon, Inc., a preclinical-stage biotechnology company focused on developing small molecules in the field of oncology, today announced it has appointed Dr. John Hood to its Board of Directors. “It’s a genuine honor to join the board of Actavalon. Actavalon is developing small molecule therapies for the some […]